EyePoint Pharmaceuticals

+$0.12 (+1.32%) Today
$0.00 (0.00%) As of 8:00 PM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell EYPT and other ETFs, options, and stocks.

About EYPT

EyePoint Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and commercialization of therapeutics that treat eye disorders. It offers FDA-approved sustained-release treatments in ophthalmology under the DEXYCU, ILUVIEN, Verisome, Retisert, and Durasert brands.

CEO
Nancy Sue Lurker
Employees
123
Headquarters
Watertown, Massachusetts
Founded
1987

EYPT Key Statistics

Market cap
314.26M
Price-Earnings ratio
—
Dividend yield
—
Average volume
111.58K
High today
$9.41
Low today
$9.00
Open price
$9.03
Volume
130.08K
52 Week high
$21.50
52 Week low
$7.30

EYPT News

Simply Wall StMay 19

EyePoint Pharmaceuticals adds US$32m to market cap in the past 7 days, though investors from five years ago are still down 55% - Yahoo Finance

This week we saw the EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT) share price climb by 11%. But don't envy holders -- looking back over 5 years the returns have

EYPT Earnings

-$1.00
-$0.67
-$0.33
$0.00
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Estimated
— per share
Actual
Expected Aug 3, Pre-Market
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure